EditPep
Berkeley, US · Founded 2022 · Delaware corporation · 1 known investors
A Berkeley spinout developing a new generation of medicines for the brain and other hard-to-treat tissues using breakthrough science from UC Berkeley and the Innovative Genomics Institute.
Biotech
Founders & leadership
EditPep was founded in 2022 by Ross Wilson and Dana Foss.
RW
Ross WilsonCo-founder
DF
Dana FossCo-founder
Board
JT
Jaromir TesarBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$8.2M disclosed across 1 round · 2024
▶$8.2MraisedDec 2024 · 1 investors · BiotechnologyRule 506(b)
▶$8.2MraisedDec 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ross WilsonExecutive Officer, Director, Promoter
- Dana FossExecutive Officer, Director, Promoter
- Jaromir TesarDirector
- Offering amount
- $8.2M
- Amount sold
- $8.2M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does EditPep do?
- A Berkeley spinout developing a new generation of medicines for the brain and other hard-to-treat tissues using breakthrough science from UC Berkeley and the Innovative Genomics Institute.
- Who founded EditPep?
- EditPep was founded by Ross Wilson, Dana Foss in 2022.
- Who are EditPep's investors?
- EditPep's investors include CALIFORNIA INNOVATION.
- How much funding has EditPep raised?
- EditPep has disclosed $8.2M raised across 1 round.
- Where is EditPep headquartered?
- EditPep is headquartered in Berkeley, US.